Biosimilars

Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing approved reference biologic drug. They undergo rigorous comparative testing to demonstrate similarity in terms of safety, efficacy, and quality, offering more affordable treatment options while maintaining high standards of patient care and regulatory oversight

    Related Conference of Biosimilars

    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in